Acura Pharmaceuticals (ACUR) Short Interest Ratio & Short Volume $0.0005 0.00 (0.00%) As of 08/7/2025 Add Compare Share Share Short Interest Stock AnalysisChartHeadlinesSEC FilingsShort InterestBuy This Stock Acura Pharmaceuticals Short Interest DataAcura Pharmaceuticals (ACUR) has a short interest of 6,300 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.9, indicating that it would take 0.9 days of the average trading volume of 228 shares to cover all short positions.Current Short Interest6,300 sharesPrevious Short Interest6,300 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$1.26Short Interest Ratio0.9 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares66,500,000 sharesPercentage of Shares Shorted0.01%Today's Trading Volume0 sharesAverage Trading Volume228 sharesToday's Volume Vs. Average0% Short Selling Acura Pharmaceuticals? Sign up to receive the latest short interest report for Acura Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartACUR Short Interest Over TimeACUR Days to Cover Over TimeACUR Percentage of Float Shorted Over Time Acura Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/20256,300 shares $1.26 No ChangeN/A0.9 $0.00 6/30/20256,300 shares $15.75 No Change0.0%0 $0.00 6/15/20256,300 shares $15.75 No Change0.0%1.9 $0.00 5/31/20256,300 shares $126.00 No Change0.0%63 $0.02 5/15/20256,300 shares $126.00 No Change0.0%5.3 $0.02 4/30/20256,300 shares $124.74 No ChangeN/A0 $0.02 4/15/20256,300 shares $124.74 No Change0.0%63 $0.02 3/31/20256,300 shares $124.74 No Change0.0%5.3 $0.02 3/15/20256,300 shares $124.74 No Change0.0%0.6 $0.02 2/28/20256,300 shares $11.34 No Change0.0%0.5 $0.00 Get the Latest News and Ratings for ACUR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acura Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/15/20256,300 shares $41.58 No Change0.0%12.6 $0.01 1/31/20256,300 shares $14.49 No ChangeN/A1 $0.00 1/15/20256,300 shares $1.26 No ChangeN/A0 $0.00 12/31/20246,300 shares $1.26 No ChangeN/A0.5 $0.00 12/15/20246,300 shares $18.90 No ChangeN/A9 $0.00 11/30/20246,300 shares $14.50 No ChangeN/A0.5 $0.00 11/15/20246,300 shares $10.71 No ChangeN/A7.9 $0.00 10/31/20246,300 shares $8.83 No ChangeN/A5.3 $0.00 10/15/20246,300 shares $6.93 No ChangeN/A21 $0.00 9/30/20246,300 shares $30.24 No ChangeN/A63 $0.00 9/15/20246,300 shares $30.24 No ChangeN/A31.5 $0.00 8/31/20246,300 shares $23.94 No ChangeN/A15.8 $0.00 8/15/20246,300 shares $22.68 No ChangeN/A63 $0.00 7/31/20246,300 shares $126.00 No ChangeN/A63 $0.02 7/15/20246,300 shares $126.00 No ChangeN/A31.5 $0.02 6/30/20246,300 shares $173.25 No ChangeN/A63 $0.03 6/15/20246,300 shares $173.25 No ChangeN/A63.4 $0.03 5/31/20246,300 shares $63.00 No ChangeN/A2.6 $0.01 5/15/20246,300 shares $25.83 No ChangeN/A31.5 $0.00 4/30/20246,300 shares $63.00 No ChangeN/A1.8 $0.01 4/15/20246,300 shares $17.64 No ChangeN/A1 $0.00 3/31/20246,300 shares $15.75 No ChangeN/A31.5 $0.00 3/15/20246,300 shares $26.46 No ChangeN/A12.6 $0.00 2/29/20246,300 shares $13.23 No ChangeN/A12.6 $0.00 2/15/20246,300 shares $6.30 No ChangeN/A31.5 $0.00 1/15/20246,300 shares $6.93 -1.6%N/A1.1 $0.00 12/31/20236,400 shares $0.00 No ChangeN/A0.7 $0.00 12/15/20236,400 shares $0.00 No ChangeN/A2.7 $0.00 11/30/20236,400 shares $0.00 No ChangeN/A32 $0.00 11/15/20236,400 shares $0.00 No ChangeN/A64 $0.00The Coin That Could Define Trump’s Crypto Presidency (Ad)When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”Discover the coin that could define Trump’s crypto presidency. 10/31/20236,400 shares $0.00 No ChangeN/A1.4 $0.00 10/15/20236,400 shares $2.56 No ChangeN/A10.7 $0.00 9/30/20236,400 shares $2.56 No ChangeN/A32 $0.00 9/15/20236,400 shares $2.56 No ChangeN/A64 $0.00 8/31/20236,400 shares $2.56 No ChangeN/A12 $0.00 8/15/20236,400 shares $2.56 No ChangeN/A10.7 $0.00 7/31/20236,400 shares $3.84 No ChangeN/A1.6 $0.00 7/15/20236,400 shares $1.92 +1.6%N/A0.8 $0.00 6/30/20236,300 shares $1.89 No ChangeN/A5.7 $0.00 6/15/20236,300 shares $315.00 No ChangeN/A1.7 $0.05 5/31/20236,300 shares $315.00 No ChangeN/A4.8 $0.05 5/15/20236,300 shares $315.00 No ChangeN/A12.6 $0.05 4/30/20236,300 shares $315.00 No ChangeN/A63 $0.05 4/15/20236,300 shares $315.00 No ChangeN/A0.1 $0.05 3/31/20236,300 shares $315.00 No ChangeN/A1.4 $0.05 3/15/20236,300 shares $315.00 No ChangeN/A7 $0.05 2/28/20236,300 shares $315.00 No ChangeN/A6.3 $0.05 2/15/20236,300 shares $315.00 No ChangeN/A7.9 $0.05 1/31/20236,300 shares $315.00 No ChangeN/A10.5 $0.05 1/15/20236,300 shares $315.00 No ChangeN/A31.5 $0.05 12/30/20226,300 shares $315.00 No ChangeN/A1.2 $0.05 12/15/20226,300 shares $315.00 -4.6%N/A1.2 $0.05 11/30/20226,600 shares $330.00 -2.9%N/A16.5 $0.05 11/15/20226,800 shares $340.00 No ChangeN/A1 $0.05 10/31/20226,800 shares $34.00 No ChangeN/A3.2 $0.01 10/15/20226,800 shares $34.00 No ChangeN/A8.5 $0.01 9/30/20226,800 shares $68.00 No ChangeN/A68 $0.01 9/15/20226,800 shares $34.00 No ChangeN/A3.8 $0.01 8/31/20226,800 shares $68.00 No ChangeN/A0.1 $0.01 8/15/20226,800 shares $476.00 -37.6%N/A6.2 $0.07 7/31/202210,900 shares $1.20 thousand -27.8%N/A0.6 $0.11 7/15/202215,100 shares $7.53 thousand -12.7%N/A1.7 $0.50 6/30/202217,300 shares $8.30 thousand +16.1%N/A2.4 $0.48 6/15/202214,900 shares $7.08 thousand +17.3%N/A5.3 $0.48 5/31/202212,700 shares $6.10 thousand -11.8%N/A0.9 $0.48 5/15/202214,400 shares $5.76 thousand -53.1%N/A2.8 $0.40 4/30/202230,700 shares $16.27 thousand +25.8%N/A3.8 $0.53 4/15/202224,400 shares $12.08 thousand -38.7%N/A1.2 $0.50 3/31/202239,800 shares $15.72 thousand -34.3%N/A4.1 $0.40 3/15/202260,600 shares $24.24 thousand -3.4%N/A11 $0.40 2/28/202262,700 shares $26.96 thousand +21.5%N/A2 $0.43 2/15/202251,600 shares $23.22 thousand +35.8%N/A7.6 $0.45 1/31/202238,000 shares $14.48 thousand +10.5%N/A1.5 $0.38 1/15/202234,400 shares $18.58 thousand +52.2%N/A3.5 $0.54 12/31/202122,600 shares $11.30 thousand +117.3%N/A0.9 $0.50 12/15/202110,400 shares $5.69 thousand No ChangeN/A0.6 $0.55 11/30/202110,400 shares $5.62 thousand -1.0%N/A1 $0.54 11/15/202110,500 shares $5.83 thousand -19.2%N/A0.3 $0.56 10/29/202113,000 shares $7.15 thousand +25.0%N/A0.8 $0.55 10/15/202110,400 shares $5.93 thousand No ChangeN/A0.9 $0.57The Coin That Could Define Trump’s Crypto Presidency (Ad)When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”Discover the coin that could define Trump’s crypto presidency. 9/30/202110,400 shares $5.48 thousand No ChangeN/A1.5 $0.53 9/15/202110,400 shares $5.88 thousand No ChangeN/A1 $0.57 8/31/202110,400 shares $6.14 thousand No ChangeN/A1.4 $0.59 8/13/202110,400 shares $6.65 thousand -13.3%N/A0.5 $0.64 7/30/202112,000 shares $7.20 thousand -8.4%N/A0.6 $0.60 7/15/202113,100 shares $8.52 thousand +24.8%N/A0.6 $0.65 6/30/202110,500 shares $6.93 thousand -3.7%N/A0.2 $0.66 6/15/202110,900 shares $6.00 thousand +4.8%N/A0.2 $0.55 5/28/202110,400 shares $3.74 thousand No ChangeN/A1.2 $0.36 5/14/202110,400 shares $3.83 thousand No ChangeN/A1.2 $0.37 4/30/202110,400 shares $4.13 thousand No ChangeN/A0.6 $0.40 4/15/202110,400 shares $3.33 thousand No ChangeN/A1.9 $0.32 3/31/202110,400 shares $3.43 thousand No ChangeN/A1.1 $0.33 3/15/202110,400 shares $3.33 thousand No ChangeN/A0.7 $0.32 2/26/202110,400 shares $4.15 thousand -5.5%N/A0.5 $0.40 2/12/202111,000 shares $4.24 thousand -60.6%N/A0.1 $0.39 1/29/202127,900 shares $6.14 thousand +31.0%N/A0.8 $0.22 1/15/202111,200 shares $2.58 thousand +7.7%N/A0.7 $0.23 12/31/202010,400 shares $1.88 thousand -7.1%N/A0.4 $0.18 12/15/202011,200 shares $2.59 thousand +7.7%N/A0.7 $0.23 11/30/202010,400 shares $2.60 thousand -65.7%N/A0.6 $0.25 11/15/202030,300 shares $7.58 thousand +154.6%N/A1.6 $0.25 10/30/202011,900 shares $2.76 thousand -7.0%N/A0.6 $0.23 10/15/202012,800 shares $3.26 thousand +23.1%N/A2.2 $0.26 9/30/202010,400 shares $2.60 thousand No ChangeN/A0.9 $0.25 9/15/202010,400 shares $2.70 thousand -28.8%N/A0.9 $0.26 8/31/202014,600 shares $3.85 thousand -16.1%N/A1.8 $0.26 8/14/202017,400 shares $5.01 thousand -1.1%N/A1.2 $0.29 ACUR Short Interest - Frequently Asked Questions What is Acura Pharmaceuticals' current short interest? Short interest is the volume of Acura Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of July 15th, investors have sold 6,300 shares of ACUR short. Learn More on Acura Pharmaceuticals' current short interest. What is a good short interest ratio for Acura Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ACUR shares currently have a short interest ratio of 1.0. Learn More on Acura Pharmaceuticals's short interest ratio. How does Acura Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Acura Pharmaceuticals: Eli Lilly and Company (0.90%), Johnson & Johnson (0.76%), AbbVie Inc. (0.89%), Merck & Co., Inc. (1.15%), Pfizer Inc. (1.75%), Bristol Myers Squibb Company (1.89%), Zoetis Inc. (1.76%), Royalty Pharma PLC (5.04%), Corcept Therapeutics Incorporated (11.96%), Jazz Pharmaceuticals PLC (9.92%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Acura Pharmaceuticals stock? Short selling ACUR is an investing strategy that aims to generate trading profit from Acura Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Acura Pharmaceuticals? A short squeeze for Acura Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ACUR, which in turn drives the price of the stock up even further. How often is Acura Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACUR, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies Eli Lilly and Company Short Squeeze Johnson & Johnson Short Squeeze AbbVie Short Squeeze Merck & Co., Inc. Short Squeeze Pfizer Short Squeeze Bristol Myers Squibb Short Squeeze Zoetis Short Squeeze Royalty Pharma Short Squeeze Corcept Therapeutics Short Squeeze Jazz Pharmaceuticals Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:ACUR) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acura Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acura Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ACUR Stock Alerts